Goldshield directors back management's takeover; Bayer faces almost 1,000 Trasylol suits in FL;

> British generic drug supplier Goldshield's independent directors have lent their weight to a takeover bid by the company's management after effectively saying a rival must massively increase its offer to win. Report

> Bayer faces almost 1,000 lawsuits in a Florida federal district court regarding its anti-bleeding drug Trasylol, according to the docket in the case. Report

> Bayer reaffirmed its full-year outlook and posted forecast-beating operating earnings. Report

> GlaxoSmithKline and Genmab got the FDA nod have won U.S. approval to sell their leukaemia drug Arzerra, marking a small positive for the British group and a major milestone for its smaller Danish partner. Report

> GlaxoSmithKline is expected to report higher third-quarter earnings before London's financial markets open Wednesday. Report

> Belgian pharmaceutical group UCB has raised as much as €750 million ($1.13 billion) through a bond offering it launched on Monday, Belgian daily De Tijd reported. Report

> India's Lupin said its second quarter net profit grew 39 percent from a year earlier, helped by higher sales of finished drugs in overseas markets. Report

> Hospital products and generic drugmaker Hospira said quarterly net earnings rose 42 percent, fueled by a new product launch, and it raised its full-year profit forecast. Report

Biotech News

> Spread the word: Roche is hiring 70 scientists over the next year for its new research center in Nutley, NJ, which is exploring new drugs for cancer, asthma and arthritis. Roche article

> Ligand Pharmaceuticals has snapped up struggling Metabasis Therapeutics for just $3.2 million. Report

> In just the latest sign of just how hot new cancer drugs have become, San Francisco-based Medivation garnered a $110 million upfront payment and a milestone package of $655 million from Astellas for global rights to its experimental prostate cancer drug. Article

> Genmab has won a $23 million milestone payment from GlaxoSmithKline on the FDA's approval of Arzerra (ofatumumab) for chronic lymphocytic leukemia. Genmab report

> Icagen's share price was battered this morning after the develop announced that it is shelving its experimental asthma drug, senicapoc, after it failed a mid-stage trial. Article

Research News

> New drug target have been discovered for the treatment of sleep deprivation. Article

> A benign adenovirus armed with a genetic payload was used to correct the sight of a dozen people suffering from a rare genetic disorder called Leber's congenital amaurosis. And their work could have broader implications in fighting macular degeneration. Report

> Are community cancer research sites reliable? Report

> Once hailed as a national hero for his groundbreaking work on new stem cell therapies, South Korean scientist Hwang Woo-suk was convicted of embezzling research funds and sentenced to a three year suspended sentence. Report

And finally ... A new report suggests that better fibromyalgia training for internists could help patients get drugs sooner. Report

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.